Macrophages in Organ Transplantation
Current immunosuppressive therapy has led to excellent short-term survival rates in organ transplantation. However, long-term graft survival rates are suboptimal, and a vast number of allografts are gradually lost in the clinic. An increasing number of animal and clinical studies have demonstrated t...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.582939/full |
id |
doaj-974f63c940864aa7b0481d49b70ce256 |
---|---|
record_format |
Article |
spelling |
doaj-974f63c940864aa7b0481d49b70ce2562020-12-08T08:38:45ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-11-011110.3389/fimmu.2020.582939582939Macrophages in Organ TransplantationFarideh Ordikhani0Venu Pothula1Rodrigo Sanchez-Tarjuelo2Stefan Jordan3Jordi Ochando4Jordi Ochando5Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesImmunología de Trasplantes, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, SpainCurrent immunosuppressive therapy has led to excellent short-term survival rates in organ transplantation. However, long-term graft survival rates are suboptimal, and a vast number of allografts are gradually lost in the clinic. An increasing number of animal and clinical studies have demonstrated that monocytes and macrophages play a pivotal role in graft rejection, as these mononuclear phagocytic cells recognize alloantigens and trigger an inflammatory cascade that activate the adaptive immune response. Moreover, recent studies suggest that monocytes acquire a feature of memory recall response that is associated with a potent immune response. This form of memory is called “trained immunity,” and it is retained by mechanisms of epigenetic and metabolic changes in innate immune cells after exposure to particular ligands, which have a direct impact in allograft rejection. In this review article, we highlight the role of monocytes and macrophages in organ transplantation and summarize therapeutic approaches to promote tolerance through manipulation of monocytes and macrophages. These strategies may open new therapeutic opportunities to increase long-term transplant survival rates in the clinic.https://www.frontiersin.org/articles/10.3389/fimmu.2020.582939/fullmacrophagesimmune tolerancetrained immunityorgan transplantationnanotherapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Farideh Ordikhani Venu Pothula Rodrigo Sanchez-Tarjuelo Stefan Jordan Jordi Ochando Jordi Ochando |
spellingShingle |
Farideh Ordikhani Venu Pothula Rodrigo Sanchez-Tarjuelo Stefan Jordan Jordi Ochando Jordi Ochando Macrophages in Organ Transplantation Frontiers in Immunology macrophages immune tolerance trained immunity organ transplantation nanotherapy |
author_facet |
Farideh Ordikhani Venu Pothula Rodrigo Sanchez-Tarjuelo Stefan Jordan Jordi Ochando Jordi Ochando |
author_sort |
Farideh Ordikhani |
title |
Macrophages in Organ Transplantation |
title_short |
Macrophages in Organ Transplantation |
title_full |
Macrophages in Organ Transplantation |
title_fullStr |
Macrophages in Organ Transplantation |
title_full_unstemmed |
Macrophages in Organ Transplantation |
title_sort |
macrophages in organ transplantation |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2020-11-01 |
description |
Current immunosuppressive therapy has led to excellent short-term survival rates in organ transplantation. However, long-term graft survival rates are suboptimal, and a vast number of allografts are gradually lost in the clinic. An increasing number of animal and clinical studies have demonstrated that monocytes and macrophages play a pivotal role in graft rejection, as these mononuclear phagocytic cells recognize alloantigens and trigger an inflammatory cascade that activate the adaptive immune response. Moreover, recent studies suggest that monocytes acquire a feature of memory recall response that is associated with a potent immune response. This form of memory is called “trained immunity,” and it is retained by mechanisms of epigenetic and metabolic changes in innate immune cells after exposure to particular ligands, which have a direct impact in allograft rejection. In this review article, we highlight the role of monocytes and macrophages in organ transplantation and summarize therapeutic approaches to promote tolerance through manipulation of monocytes and macrophages. These strategies may open new therapeutic opportunities to increase long-term transplant survival rates in the clinic. |
topic |
macrophages immune tolerance trained immunity organ transplantation nanotherapy |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2020.582939/full |
work_keys_str_mv |
AT faridehordikhani macrophagesinorgantransplantation AT venupothula macrophagesinorgantransplantation AT rodrigosancheztarjuelo macrophagesinorgantransplantation AT stefanjordan macrophagesinorgantransplantation AT jordiochando macrophagesinorgantransplantation AT jordiochando macrophagesinorgantransplantation |
_version_ |
1724390648396644352 |